Literature DB >> 26026308

The value of preoperative screening colonoscopies in patients with biliary tract cancer.

Keita Itatsu1, Yukihiro Yokoyama2, Tomoki Ebata2, Tsuyoshi Igami2, Gen Sugawara2, Keisuke Uehara2, Takashi Mizuno2, Masahiko Ando3, Hidemi Goto4, Masato Nagino5.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the value of preoperative screening colonoscopies in patients with biliary tract cancer.
METHODS: A total of 544 patients with biliary tract cancer who underwent preoperative screening colonoscopies between January 2005 and December 2012 were retrospectively analyzed.
RESULTS: Synchronous colorectal neoplasia was detected in 199 patients (36.7 %), with adenocarcinomas detected in 21 (3.9 %) patients, carcinoids in two (0.4 %) patients, and adenomas in 176 (32.4 %) patients. Of those with adenomas, 32 patients were diagnosed with advanced adenomas, defined as adenomas with a maximum diameter of >1 cm, villous histology, or high-grade dysplasia because these characteristics implied the risk of malignant transformation. Fifty-five (10.1 %) of the patients with colorectal neoplasia required resection (11 surgical and 44 endoscopic resections). There were no major adverse events related to the resection. Univariate and multivariate analyses revealed that smoking status [ex-smoker + current smoker vs. non-smoker: odds ratio (OR) 2.32; 95 % confidence interval (CI) 1.30-4.21] and advanced age (≥70 vs. ≤69 years: OR 2.22; 95 % CI 1.24-3.91) were independent risk factors of having a colorectal neoplasia that required resection.
CONCLUSIONS: In patients with biliary tract cancer, preoperative screening colonoscopy was feasible and provided valuable clinical information. Synchronous colorectal neoplasia was detected in a substantial number of patients. Preoperative screening colonoscopies should be considered especially in high-risk patients such as smokers and elderly patients.

Entities:  

Keywords:  Biliary tract cancer; Cholangiocarcinoma; Colonoscopy; Colorectal cancer; Synchronous neoplasia

Mesh:

Year:  2015        PMID: 26026308     DOI: 10.1007/s00535-015-1092-x

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  40 in total

Review 1.  Screening for colorectal cancer: current status in Japan.

Authors:  H Saito
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

2.  Gastric cancer patients at high-risk of having synchronous cancer.

Authors:  Jun Ho Lee; Ja Seong Bae; Keun Won Ryu; Jong Seok Lee; Sook Ryun Park; Chan Gyoo Kim; Myoung Cheorl Kook; Il Ju Choi; Young Woo Kim; Jae-Gahb Park; Jae-Moon Bae
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

3.  Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients.

Authors:  Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Yu Takahashi; Yuji Nimura; Masato Nagino
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

4.  Synchronous and metachronous cancers in patients with gastric cancer.

Authors:  Bang Wool Eom; Hyuk-Joon Lee; Moon-Won Yoo; Jae Jin Cho; Woo Ho Kim; Han-Kwang Yang; Kuhn Uk Lee
Journal:  J Surg Oncol       Date:  2008-08-01       Impact factor: 3.454

5.  Multiple primary malignancies involving colorectal cancer--clinical characteristics and prognosis with reference to surveillance.

Authors:  Won-Suk Lee; Jung Nam Lee; Sangtae Choi; Min Jung; Jeong-Heum Baek; Woon Kee Lee
Journal:  Langenbecks Arch Surg       Date:  2009-09-09       Impact factor: 3.445

Review 6.  Colorectal cancer screening: practice guidelines.

Authors:  David Lieberman
Journal:  Dig Dis       Date:  2012-11-23       Impact factor: 2.404

7.  Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea.

Authors:  S B Lim; S Y Jeong; H S Choi; D K Sohn; C W Hong; K H Jung; H J Chang; J G Park; I J Choi; C G Kim
Journal:  Int J Colorectal Dis       Date:  2007-08-28       Impact factor: 2.571

8.  Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer.

Authors:  Shin Saito; Yoshinori Hosoya; Kazutomo Togashi; Kentaro Kurashina; Hidenori Haruta; Masanobu Hyodo; Koji Koinuma; Hisanaga Horie; Yoshikazu Yasuda; Hideo Nagai
Journal:  Surg Today       Date:  2007-12-24       Impact factor: 2.549

9.  Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial.

Authors:  Wendy Atkin; Edward Dadswell; Kate Wooldrage; Ines Kralj-Hans; Christian von Wagner; Rob Edwards; Guiqing Yao; Clive Kay; David Burling; Omar Faiz; Julian Teare; Richard J Lilford; Dion Morton; Jane Wardle; Steve Halligan
Journal:  Lancet       Date:  2013-02-14       Impact factor: 79.321

10.  Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan.

Authors:  T Okusaka; K Nakachi; A Fukutomi; N Mizuno; S Ohkawa; A Funakoshi; M Nagino; S Kondo; S Nagaoka; J Funai; M Koshiji; Y Nambu; J Furuse; M Miyazaki; Y Nimura
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

View more
  1 in total

1.  High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.

Authors:  Bunchorn Siripongpreeda; Chulabhorn Mahidol; Navara Dusitanond; Tassanee Sriprayoon; Bunlung Muyphuag; Thaniya Sricharunrat; Narongchai Teerayatanakul; Watanya Chaiwong; Wipra Worasawate; Prassanee Sattayarungsee; Juthamas Sangthongdee; Jirapa Prarom; Gaidganok Sornsamdang; Kamonwan Soonklang; Kasiruck Wittayasak; Chirayu U Auewarakul
Journal:  BMC Gastroenterol       Date:  2016-08-23       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.